Veergen, Inc.


Veergen, Inc. is a new biomedical technology start-up with the mission of developing vaccines that will be widely deployed to prevent outbreaks of emerging and prevalent viral diseases that affect global populations. We have developed a vaccine platform utilizing an RNA replicon coding for viral antigens that are packaged in a viral shell and aimed at inducing long-lasting cell-mediated immune response.